Cargando…
Feasibility and safety of angiotensin II administration in general ward patients during COVID-19 pandemic: a case series
Autores principales: | Morselli, Federica, Vitali, Giordano, Brioschi, Elena, Di Terlizzi, Gaetano, Belletti, Alessandro, Lombardi, Gaetano, Senarighi, Giacomo, Neto, Ary Serpa, Zangrillo, Alberto, Landoni, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692555/ https://www.ncbi.nlm.nih.gov/pubmed/38046869 http://dx.doi.org/10.51893/2020.4.RL1 |
Ejemplares similares
-
Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series
por: Zangrillo, Alberto, et al.
Publicado: (2020) -
Home ventilators for invasive ventilation of patients with COVID-19
por: Monti, Giacomo, et al.
Publicado: (2023) -
Angiotensin II infusion and markers of organ function in invasively ventilated COVID-19 patients
por: Zangrillo, Alberto, et al.
Publicado: (2023) -
Recent exposure to smoking and COVID-19
por: Landoni, Giovanni, et al.
Publicado: (2023) -
A double‐blind randomised feasibility trial of angiotensin‐2 in cardiac surgery(*)
por: Coulson, T. G., et al.
Publicado: (2022)